DXR - Wutah pendapatan taunan sajrone rolas wulan kepungkur Daxor Corporation

Daxor Corporation (DXR) is scaling the delivery of blood monitoring systems to specialized medical centers, having reached an operational efficiency plateau. Steady hospital demand and adherence to clinical protocols ensure the business remains resilient to macroeconomic headwinds. The historical year-over-year revenue growth trend over the last 12 months on the GURU.Markets chart confirms this momentum, with the indicator currently standing at -86.30.
Daxor Corporation - rincian analitis lan metrik utama (DXR)

This indicator calculates the percentage change in revenue over the last twelve months relative to the same period last year. This metric reflects the actual dynamics of business expansion, excluding seasonal distortions and one-time accounting adjustments. For Daxor Corporation (DXR), the value -86.30 confirms the effective commercialization of developments by their high-end engineering team. It is critical for investors to monitor the sustainability of this trend. By analyzing the annual growth rate of sales volume on an LTM basis, one can promptly diagnose a shift in the company's development phase.